Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
Healthy Volunteers
NCT06857344

Reinforcement Learned Automatic Anesthesia System During Painless Gastrointestinal Endoscopy

Led by Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd. · Updated on 2025-08-15

164

Participants Needed

5

Research Sites

21 weeks

Total Duration

On this page

Sponsors

B

Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.

Lead Sponsor

Z

Zhengzhou Central Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical trial is to compare the performance difference between trained model and clinical professionals in anesthesia control during gastrointestinal endoscopy. The participants would include adults aged between 18-65 years old with ASA scores I-II. The main questions it aims to answer are: * Can AI model successfully and safely perform anesthesia during gastrointestinal endoscopy? * Researchers hypothesis that anesthesia performed by professionals is not inferior to those performed by AI model. The researchers will compare the results of the AI group with the traditional group to see if both groups have similar success rates in performing anesthesia. Participants will fast for 8 hours before the procedure, and drinking water will be prohibited for 2 hours after taking the intestinal purgatives.

CONDITIONS

Official Title

Reinforcement Learned Automatic Anesthesia System During Painless Gastrointestinal Endoscopy

Who Can Participate

Age: 18Years - 65Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 to 65 years
  • American Society of Anesthesiologists (ASA) physical status class I or II
  • Expected operation duration less than 1 hour
Not Eligible

You will not qualify if you...

  • History of cardiac, hepatic, renal, or metabolic disorders including diabetes, hypertension, or sleep apnea
  • Known allergy to opioids or ciprofloxacin components
  • Cachexia
  • Hypothermia
  • History of narcotic abuse or chronic alcoholism
  • Obesity with BMI greater than 30
  • Patients with apnea
  • Current pregnancy or lactation
  • History of substance abuse or alcohol dependence
  • Participation in any other drug clinical trial within the past 3 months
  • Procedure termination due to gastric retention or inadequate bowel preparation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

Anxi County Hospital

Anxi, Fujian, China

Actively Recruiting

2

Jinjiang Municipal Hospital, Shanghai Sixth People's Hospital Fujian Campus

Jinjiang, Fujian, China

Actively Recruiting

3

Xinzheng Public People's Hospital

Xinzheng, Henan, China

Actively Recruiting

4

Henan Provincial People's Hospital

Zhengzhou, Henan, China

Actively Recruiting

5

Zhengzhou Central Hospital

Zhengzhou, Henan, China

Actively Recruiting

Loading map...

Research Team

D

Dr. Chu

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here